Sign Up RSS LinkedIn Blogs Twitter Share Alumni

Areas of Practice

Industries

Honors and Awards

Memberships and Affiliations

Investment Adviser Legal & Regulatory Subcommittee, National Society of Compliance Professionals

Business Law Section, American Bar Association

State Regulation of Securities Committee, American Bar Association

Securities Regulation Section, Philadelphia Bar Association

Education

J.D., Rutgers University School of Law - Camden, 2007

  • Associate Articles Editor, Rutgers Journal of Law and Religion

M.B.A., Drexel University, 2001

  • Member, Beta Gamma Sigma, Business Honor Society

B.A., Brandeis University, 1990

Bar Admission(s)

Photo of Justin B. Ettelson

Justin B. Ettelson

Associate
Philadelphia
Centre Square West
1500 Market Street, 38th Floor
Philadelphia, PA 19102-2186

Justin Ettelson focuses his practice on corporate and securities transactions, including securities law and compliance, general corporate matters and broker-dealer and investment adviser regulation. As a member of the Securities Transactions and Regulations, Mergers and Acquisitions, and White Collar and Government Enforcement practices, Justin writes frequently on matters related to securities law.

Prior to joining Saul Ewing, Justin was Supervisor of Examiners in the Philadelphia District Office of the Financial Industry Regulatory Authority (FINRA). In this position, he co-managed District operations and developed and executed the District's broker-dealer examination program, including supervising the conduct of examinations for compliance with federal securities laws and FINRA and Municipal Securities Rulemaking Board (MSRB) rules and regulations. He assisted regional attorneys in the prosecution of enforcement actions and counseled FINRA member firms on regulatory and technology issues. Justin also routinely interacted with other self-regulatory organizations and federal and state securities agencies.

Prior to joining FINRA, Justin was a manager in the Examinations Department of the Philadelphia Stock Exchange where he supervised examinations of the Exchange’s market makers, floor brokers and specialists.

Securities Matters

Justin counsels public and private companies regarding compliance with the Securities Act of 1933, the Securities Exchange Act of 1934, and related rules and regulations. He also counsels public companies on maintaining compliance with NASDAQ and New York Stock Exchange listing standards and Over-The-Counter Bulletin Board (OTCBB) eligibility requirements. Specifically, Justin counsel clients with respect to:

  • Registration and listing of securities
  • Periodic reporting on Forms 10-K, 10-Q and 8-K
  • Confidential treatment requests pertaining to SEC filings
  • Proxy statements for annual and special shareholder meetings
  • Section 16 Reporting
  • Private placement of securities in compliance with federal and state registration exemptions
  • Executive compensation disclosure issues
  • Compliance with Rule 144
  • Director and Officer Questionnaires
  • Director independence and related party transactions

Broker-Dealer and Investment Adviser Regulation

Justin counsels broker-dealers and investment advisers in all aspects of compliance with federal and state registration requirements, the Investment Advisers Act of 1940, and compliance with SEC, FINRA and MSRB rules and regulations. He also advises clients on the design and implementation of compliance programs and systems.

Mergers and Acquisitions

Justin represent both buyers and sellers in a variety of industries in merger and asset transactions, strategic acquisitions and stock sales.

Experience

Mergers and Acquisitions

  • Regular representation of reinsurance company in connection with structuring and acquisition of over $200 million in structured settlement backed notes from various issuers
  • Representing the Taiwan-based buyer -- one of the world's top 10 solar cell manufacturers -- of a solar module manufacturing business and acquisition of a license of related intellectual property
  • Representation of a company that provides business process outsourcing for Medicare, Medicaid and group retiree health plans in connection with the company's sale to a third party buyer for $170 million
  • Representation of a Nasdaq-listed biotechnology company focusing on the development of medicines for cancer and diabetes/obesity patients in a $200 million Rule 144A offering of 3% convertible senior subordinated notes
  • Representation of real estate funds in the private placement of limited partnership interests
  • Representation of a FINRA registered broker-dealer in the company's merger with a separately registered broker-dealer entity
  • Negotiation of broker-dealer branch office affiliation agreements
  • Performance of internal reviews of broker-dealer and investment adviser compliance programs and systems  

Articles, Alerts & Newsletters